JWH-307
 | |
| Systematic (IUPAC) name | |
|---|---|
| (5-(2-fluorophenyl)-1-pentylpyrrol-3-yl)-naphthalen-1-ylmethanone | |
| Clinical data | |
| |
| Identifiers | |
914458-26-7  | |
| PubChem | CID 16049783 |
| ChemSpider | 13178178 |
| Chemical data | |
| Formula | C26H24FNO |
| 385.472 g/mol | |
|
SMILES
| |
| |
| (what is this?) (verify) | |
JWH-307 is an analgesic drug used in scientific research, which acts as a cannabinoid agonist at both the CB1 and CB2 receptors. It is somewhat selective for the CB2 subtype, with a Ki of 7.7nM at CB1 vs 3.3nM at CB2.[1] It was discovered by, and named after, Dr. John W. Huffman. JWH-307 was detected as an ingredient in synthetic cannabis smoking blends in 2012, initially in Germany.[2][3]
See also
References
- ↑ Huffman JW, Padgett LW, Isherwood ML, Wiley JL, Martin BR. 1-Alkyl-2-aryl-4-(1-naphthoyl)pyrroles: New high affinity ligands for the cannabinoid CB1 and CB2 receptors. Bioorganic & Medicinal Chemistry Letters 2006; 16:5432-5435.
- ↑ Ernst, L.; Krüger, K.; Lindigkeit, R.; Schiebel, H. M.; Beuerle, T. (2012). "Synthetic cannabinoids in "spice-like" herbal blends: First appearance of JWH-307 and recurrence of JWH-018 on the German market". Forensic Science International 222 (1–3): 216–22. doi:10.1016/j.forsciint.2012.05.027. PMID 22748479.
- ↑ Kneisel, S.; Auwärter, V. (2012). "Analysis of 30 synthetic cannabinoids in serum by liquid chromatography-electrospray ionization tandem mass spectrometry after liquid-liquid extraction". Journal of Mass Spectrometry 47 (7): 825–835. doi:10.1002/jms.3020. PMID 22791249.